Home » Topics » BioWorld Science

BioWorld Science
RSS

Endothelin-modulating compounds developed at Texas Biotechnology

Dec. 5, 1997

Chiroscience files MAA for Chirocaine

Dec. 5, 1997

SKB reveals selective inhibitors of bacterial enzyme

Dec. 5, 1997

DuPont Merck develops novel CRF antagonists

Dec. 5, 1997

New tacrine analogue designated for further development

Dec. 5, 1997

Oncaspar approved in Canada

Dec. 5, 1997

VIMRx: Q3 1997 highlights

Dec. 5, 1997

Sugen initiates phase II prostate cancer trial with SU-101

Dec. 5, 1997

Preclinical results reported for JTE-522, a selective COX-2 inhibitor

Dec. 5, 1997

Genta to evaluate G-3139 in U.S. prostate cancer trial

Dec. 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...